Integra Lifesciences Holdings IART
NASDAQ IART
$14.89 +0.36 (+2.48%)
As of: Nov 11, 2026 · 3:28 PM EST

Integra Lifesciences Holdings (IART) Liabilities from Discontinued Operations (2014 - 2022)

Updated

Integra Lifesciences Holdings (IART) recorded Liabilities from Discontinued Operations of $2.3 million in Q2 2022.

Analysis

Integra Lifesciences Holdings (IART) Liabilities from Discontinued Operations (2014 - 2022) Analysis & Trends

At the end of FY2020, Integra Lifesciences Holdings reported Liabilities from Discontinued Operations of $11.75 million.

  • The Q2 2022 figure is the highest quarterly Liabilities from Discontinued Operations since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn
10 Integra Lifesciences Holdings 1.13 Bn 15.08 Mn 209.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 2.30 Mn
Dec 31, 2020 11.75 Mn
Sep 30, 2020 12.35 Mn
Dec 31, 2014 2.63 Mn
API Access

Integra Lifesciences Holdings Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=IART&period=max&api_key=YOUR_API_KEY